IPICK Blocking for TKA With Moderate Flexion Contracture

NCT ID: NCT04603950

Last Updated: 2022-07-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

42 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-11-01

Study Completion Date

2021-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Clinical effect of intermittent multiple IPICK blocking on TKA for knee osteoarthritis with flexion contracture between 5 ° and 10 °

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

From October 2020 to January 2021, 40 knee osteoarthritis patients with flexion contracture between 5 ° and 10 ° total knee arthroplasty are enrolled in this study. 20 patients are treated with Adductor Canal Block + Infiltration between the Popliteal Artery and Capsule of the Knee, and 20 patients are treated with Adductor Canal Block alone.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Knee Osteoarthritis Flexion Contracture of Knees Anesthesia, Local

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

study group

The first 20 patients received Continue Adductor Canal Block + Infiltration between the Popliteal Artery and Capsule of the Knee

Group Type EXPERIMENTAL

CACB+IPACK

Intervention Type PROCEDURE

continue adductor canal block plus Infiltration between the Popliteal Artery and Capsule of the Knee

control group

The second 20 patients received Continue Adductor Canal Block alone

Group Type SHAM_COMPARATOR

CACB

Intervention Type PROCEDURE

continue adductor canal block

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

CACB+IPACK

continue adductor canal block plus Infiltration between the Popliteal Artery and Capsule of the Knee

Intervention Type PROCEDURE

CACB

continue adductor canal block

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. The diagnosis was knee osteoarthritis
2. The flexion contracture was between 5 and 10 degrees
3. ASA grade I-III

Exclusion Criteria

1. Lower extremity neuropathy.
2. Contraindications of nerve anesthesia or regional anesthesia.
3. unable to cooperate, allergic to the drugs used in this study.
4. Non steroidal anti-inflammatory drugs are not tolerated.
5. chronic opioid consumption (daily or almost daily use)
Minimum Eligible Age

50 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The First Hospital of Jilin University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The First Hospital of Jilin University

Changchun, , China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

QiXin2

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The personalKNEE Trial
NCT06507046 RECRUITING NA